Agentus Therapeutics Limited
Other business support service activities n.e.c. · London
ActiveUnited KingdomIncorporated 2017Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
10855876- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2017-07-07
- Jurisdiction
- —
- Registered office
- 5, NEW STREET SQUARE, LONDON, EC4A 3TW, UNITED KINGDOM
Classification
1 SIC codes82990
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsA coordinated strategy to scale-up advanced therapies for patient in ManchesterInnovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants£0awarded
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 11 other participants
£0
awarded
Manchester University NHS Foundation Trust£270,594
The Christie NHS Foundation Trustlead£252,199
AgenTus Therapeutics Ltd£0
Sheffield Teaching Hospitals NHS Foundation Trust£0
A coordinated strategy to scale-up advanced therapies for patient in ManchesterISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants£1,759,515whole project
A coordinated strategy to scale-up advanced therapies for patient in Manchester
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 12 other participants
£1,759,515
whole project
The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca UK LimitedChaucer Group LimitedDatatrial LimitedFormedix LimitedGlobal Life Sciences Solutions Operations UK LtdInstil Bio (UK) LimitedManchester University NHS Foundation TrustSheffield Teaching Hospitals NHS Foundation TrustThe Christie Pathology Partnership LLPThe University Of Manchester
A coordinated strategy to scale-up advanced therapies for patients in ManchesterInnovate UK · Collaborative R&D · 2018-03-01 – 2022-04-30 · with 12 other participants£0awarded
A coordinated strategy to scale-up advanced therapies for patients in Manchester
Innovate UK · Collaborative R&D · 2018-03-01 – 2022-04-30 · with 12 other participants
£0
awarded
The Christie NHS Foundation Trustlead£1,997,573
Manchester University NHS Foundation Trust£1,141,375
AgenTus Therapeutics Ltd£0
Northern Care Alliance NHS Foundation Trust£0
A coordinated strategy to scale-up advanced therapies for patients in ManchesterISCF · Collaborative R&D · 2018-03-01 – 2022-04-29 · with 12 other participants£7,561,118whole project
A coordinated strategy to scale-up advanced therapies for patients in Manchester
ISCF · Collaborative R&D · 2018-03-01 – 2022-04-29 · with 12 other participants
£7,561,118
whole project
The Christie NHS Foundation TrustleadAgentus Therapeutics LtdAptus Clinical LimitedAstrazeneca PLCAsymptote LimitedCellular Therapeutics LtdChaucer Group LimitedDatatrial LimitedFormedix LimitedManchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustThe Christie Pathology Partnership LLPThe University Of Manchester